Foghorn Therapeutics

0 followers


Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integ... Read more

Industries

Headquarters

Employees

Links

Org chart

Adrian Gottschalk

Collapse
Samuel Agresta
Chief Medical Officer
Michael Lacascia
Chief Legal Officer
Steven Bellon
Chief Scientific Officer
Carlos Costa
Chief People Officer
Chong-Hui Gu
Head Of CMC And QA
Murphy Hentemann
VP, Program Leadership
Ben Strain
VP, Investor Relations & Corporate Communications
Danette L. Daniels
Vice President, Protein Degradation Platform
Kevin Wilson
VP, Chemistry
Marina Nelen
VP, Drug Discovery
Gromek Smolen
Vp, Head Of Biology
Karin Hellsvik
Vice President, Corporate Affairs & Investor Relations, Chief Of Staff To The CEO
Saurabh Sewak
Head Of Business Development And Vp, Corporate Development
Dan Dinu
Vice President, Head Of IT
Andrew Germain
Vice President, Legal
Alfonso Quintás-Cardama
Chief Medical Officer
Anna Rivkin
Chief Business Officer
Kristian F. Humer
Chief Financial Officer